Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods

Brain

Volumn 121, Issue 7, 1998, Pages 1305-1312

  Riahi, F ^a   Zijdenbos, A ^a   Narayanan, S ^a   Arnold, D ^a   Francis, G ^a   Antel, J ^a   Evans, A C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Disability; Lesion load; MRI; Multiple sclerosis

Indexed keywords

ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; DISABILITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRAMIDAL TRACT; RELAPSE; REMISSION;

BRAIN; DISABILITY EVALUATION; DISABLED PERSONS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PYRAMIDAL TRACTS; RECURRENCE;

EID: 2642707517     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.7.1305     Document Type: Article

References (37)

1. Arnold DL, Riess GT, Mattews PM, Francis GS, Collins DL, Wolfson C, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994; 36: 76-82.
2. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment. J Neurol 1997; 244: 76-84.
3. Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991; 114: 1271-80.
4. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput Assist Tomogr 1994; 18: 192 - 205.
5. Collins DL, Holmes CJ, Peters TM, Evans AC. Automatic 3d model-based neuroanatomical segmentation. Hum Brain Mapp 1995; 3: 190-208.
6. Evans AC, Dai W, Collins L, Neelin P, Marrett S. Warping of a computerized 3d atlas to match brain image volumes for quantitative neuroanatomical and functional analysis. Proceedings of SPIE - The International Society for Opitical Engineering; Vol. 1445 Image Processing 1991: 236-46.
7. Evans AC, Collins DL, Milner B. An MRI-based stereotactic atlas from 250 young normal subjects [abstract]. Soc Neurosci Abstr 1992; 18: 408.
8. Evans AC, Kamber M, Collins DL, MacDonald D. An MRI-based probabilistic atlas of neuroanatomy. In: Shorvon SD, Fish DR, Andermann F. Magnetic resonance scanning and epilepsy. Bydder GM, Stefan H, editors. New York: Plenum Press; 1994a. p. 263-74.
9. Evans AC, Collins DL, Mills SR, Brown ED, Peters TM. 3D statistical neuroanatomical models from 305 MRI volumes. Proceedings of the IEEE Nuclear Science Symposium Medical Imaging Conference 1994b; 3: 1813-7.
10. Evans AC, Frank JA, Antel J, Miller DH. Evaluation of multiple sclerosis lesion load: comparison of image processing techniques. Ann Neurol 1997; 41: 125-32.
11. Filippi M, Horsfield MA, Morrissey SP, MacManus DG, Rudge P, McDonald WI, et al. Quantitative brain MRI lesion load predicts the course of Clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994; 44: 635-41.
12. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995a; 118: 1601-12.
13. 2weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995b; 45: 255-60.
14. Filippi M, van Waesberghe JH, Horsfield MA, Bressi S, Gasperini C, Yousry TA, et al. Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. Neurology 1997; 49: 371-7.
15. Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials. Ann Neurol 1994; 36 Suppl: S86-90.
16. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36: 62-7.
17. Koopmans RA, Li DKB, Grochowski E, Cutler PJ, Paty DW. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989; 25: 74-81.
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
19. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701-8.
20. Lycklama a Nijeholt GJ, Barkof F. Scheltens P, Castelijns JA, Ader H, van Waesberghe JH. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. Am J Neuroradiol 1997; 18: 1041-8.
21. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18: 319-34.
22. McDonald WI, Miller DH, Thompson AJ. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. Ann Neurol 1994; 36: 14-8.
23. Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 1994; 36 Suppl: S91-94.
24. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996; 39: 6-16.
25. Nauta JJ, Thompson AJ, Barkhof F, Miller DH. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs. J Neurol Sci 1994; 122: 6-14.
26. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial. Neurology 1990; 40: 971-5.
27. Paty DW, Li DK. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-1. Comment in: Neurology 1993; 43: 641-3.
28. Paty DW, Li DK. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-1. Comment in: Neurology 1993; 43: 641-3.
29. Paty DW, Li DK, Oger JJ-F, Kastrukoff L, Koopmans R, Tanton E, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994; 36 Suppl: S95-6.
30. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme; 1988.
31. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study [see comments]. BMJ 1990; 300: 631-4. Comment in: BMJ 1990; 300: 1272.
32. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study [see comments]. BMJ 1990; 300: 631-4. Comment in: BMJ 1990; 300: 1272.
33. Thompson AJ, Miller D, Youl B, MacManus D, Moore S, Kingsley D, et al. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992; 42: 60-3.
34. 1-weighted) spin-echo images. Neurology 1995; 45; 1684-90.
35. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology 1988; 38; 1793-8.
36. Zhao GJ, Koopmans RA, Li DKB, Redekop K, Morrison W, Nelson J, et al. Corticspinal tract lesions in multiple sclerosis: relationship between MRI activity and clinical course [abstract]. Neurology 1993; 43 (4 Suppl): A246.
37. Zijdenbos AP, Dawant BM. Brain segmentation and white matter lesion detection in MR images. Crit Rev Biomed Eng 1994; 22:401-65